Patent Assignment
Reel/Frame 051476/0874
Merger
Recorded: 2020-01-10
Pages: 8
Assignor
VALLINEX, INC.
Executed: 2013-11-20
Assignee
CENTREXION I, INC.
509 S. EXETER STREET, SUITE 202, BALTIMORE, MARYLAND, 21202
Covered Property
(1)
Injectable Resiniferatoxin
Application:
16/737,557 →
Publication:
US 2020/0375926
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 10, 2020
From: CENTREXION I, INC.
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 051476/0812 →
Assignment of Assignor's Interest
Jan 10, 2020
From: ARCION THERAPEUTICS, INC.
To: VALLINEX, INC.
Reel/Frame 051476/0894 →
Assignment of Assignor's Interest
Jan 10, 2020
From: ALGORX PHARMACEUTICALS, INC.; ANESIVA INC.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 051476/0913 →
Assignment of Assignor's Interest
Jan 10, 2020
From: BURCH, RONALD M.; CARTER, RICHARD B.; LAZAR, JEFFREY D.
To: ALGORX PHARMACEUTICALS, INC.
Reel/Frame 051476/0958 →
Security Interest
Jul 12, 2023
From: CENTREXION THERAPEUTICS CORPORATION
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 064256/0125 →
Release of Security Interest
Nov 21, 2025
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 073683/0099 →